CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Sector dividends Charles River Laboratories International, Inc.

Stocks

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - NYSE Other stock markets 04:00:02 2026-07-10 pm EDT			5-day change	1st Jan Change
233.41 ^USD	-0.08%		+1.18%	+17.01%

Jul. 09	Morgan Stanley Adjusts Price Target on Charles River Laboratories International to $260 From $220	MT
Jul. 07	Evercore ISI Adjusts Price Target on Charles River Laboratories International to $260 From $220	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Dividend Yield (N)	Dividend Yield (N+1)	P/E (N)	Price to Book (N)	EV / Sales (N)	EV / EBITDA (N)	EV / EBIT (N)	Capi.($)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-.--%	-.--%	38.05x	3.41x	3.39x	13.18x	16.03x	11.24B
LONZA GROUP AG	0.93%	1.06%	35.38x	4.49x	6.18x	19.12x	26.54x	50.73B
REVOLUTION MEDICINES, INC.	-.--%	-.--%	-23.4x	18.4x	342.07x	-22.1x	-21.39x	39.73B
IQVIA HOLDINGS INC.	-.--%	-.--%	25.29x	4.79x	2.8x	12.09x	18.42x	34.69B
BEONE MEDICINES AG	-.--%	-.--%	45.73x	6.69x	4.51x	28.9x	34.11x	33.21B
CELLTRION, INC.	0.42%	0.46%	27.05x	2.21x	7.93x	19.91x	23.37x	26.76B
MEDPACE HOLDINGS, INC.	-.--%	-.--%	31.75x	15.82x	5.12x	23.32x	24.46x	15.37B
EUROFINS SCIENTIFIC SE	1.12%	1.3%	23.95x	2.51x	2.04x	8.96x	14.17x	13.78B
ICON PUBLIC LIMITED COMPANY	-.--%	-.--%	23.74x	1.32x	1.89x	11.45x	13.01x	12.85B
ABIVAX	-.--%	-.--%	-33.62x	10.2x	128.84x	-36.68x	-63.82x	12.11B
BIO-TECHNE CORPORATION	0.45%	0.45%	61.2x	5.12x	9.14x	25.96x	28.38x	11.11B
TEMPUS AI, INC.	-.--%	-.--%	-29.15x	25.77x	6.96x	170.7x	-539.26x	10.46B
IONIS PHARMACEUTICALS, INC.	-.--%	-.--%	-16.16x	233.3x	10.54x	-15.6x	-14.78x	9.63B
APOGEE THERAPEUTICS, INC.	-.--%	-.--%	-30.97x	8.96x	994.1x	-26.35x	-25.82x	10.02B
KYMERA THERAPEUTICS, INC.	-.--%	-.--%	-33.88x	8.72x	100.38x	-22.52x	-21.72x	9.82B
PRAXIS PRECISION MEDICINES, INC.	-.--%	-.--%	-21.4x	8.09x	2596.69x	-18.09x	-17.17x	9.06B
ALKERMES PLC	-.--%	-.--%	-135.38x	4.7x	5.32x	28.22x	161.68x	8.66B
PROTAGONIST THERAPEUTICS, INC.	-.--%	-.--%	33.56x	-	15.44x	27.56x	29.86x	8.45B
QIAGEN N.V.	-.--%	0.45%	19.33x	2.26x	4.28x	11.32x	14.69x	8.58B
Average	0.15%	0.2%	2.16x	20.37x	223.56x	13.65x	-15.75x	17.7B
Weighted average by Cap.	0.23%	0.28%	11.27x	14.47x	151.83x	12.45x	-3.79x